SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-20-005567
Filing Date
2020-03-18
Accepted
2020-03-18 16:29:16
Documents
102
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K navb20191231_10k.htm 10-K 1979253
2 EXHIBIT 4.3 ex_176385.htm EX-4.3 25904
3 EXHIBIT 10.27 ex_176346.htm EX-10.27 90402
4 EXHIBIT 10.28 ex_176004.htm EX-10.28 99703
5 EXHIBIT 21.1 ex_176006.htm EX-21.1 4136
6 EXHIBIT 23.1 ex_176007.htm EX-23.1 4199
7 EXHIBIT 24.1 ex_176008.htm EX-24.1 13872
8 EXHIBIT 31.1 ex_176009.htm EX-31.1 9689
9 EXHIBIT 32.1 ex_176011.htm EX-32.1 4864
16 logoz01.jpg GRAPHIC 13399
17 marcum.jpg GRAPHIC 5283
18 navb20191231_10kimg001.gif GRAPHIC 16509
  Complete submission text file 0001437749-20-005567.txt   10395166

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT navb-20191231.xml EX-101.INS 1974732
11 XBRL TAXONOMY EXTENSION SCHEMA navb-20191231.xsd EX-101.SCH 100153
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE navb-20191231_cal.xml EX-101.CAL 49216
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE navb-20191231_def.xml EX-101.DEF 826017
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE navb-20191231_lab.xml EX-101.LAB 613433
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE navb-20191231_pre.xml EX-101.PRE 843789
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35076 | Film No.: 20724895
SIC: 2835 In Vitro & In Vivo Diagnostic Substances